热点 来源:新京报 时间:2023-03-06 11:06:53
(资料图片)
中信建投证券研报认为,国内流感抬头,诊疗方案成熟、涉及众多企业,整体影响有限。流感有成熟的疫苗、药物和诊断方案,所以对民众生活影响有限。产业链相关(疫苗、诊断试剂、抗病毒药物及对症治疗药物、药店)等公司可能均有受益,但是要看竞争格局。
(文章来源:新京报)
标签: 中信建投
23-03-06
23-03-06
23-03-06
23-03-05
23-03-05
23-03-05
23-03-05
23-03-05
23-03-05
23-03-05
23-03-05
23-03-05
23-03-05
23-03-05
23-03-05
23-03-05
23-03-05
23-03-05
23-03-05
23-03-05
23-03-05
23-03-05
23-03-05
23-03-05
23-03-05
23-03-05
23-03-05
23-03-05
23-03-05
23-03-05
23-03-05
23-03-05
23-03-05
23-03-05
23-03-05
23-03-05
23-03-05
23-03-05
23-03-05
23-03-05
23-03-05
23-03-05
23-03-05
23-03-05
23-03-05
23-03-05
23-03-05
23-03-05
23-03-05
23-03-05
23-03-05
23-03-05
23-03-05
23-03-05
23-03-05
23-03-05
23-03-05
23-03-05
23-03-05
23-03-05
22-09-30
22-04-11
22-04-11
22-04-11
22-04-11
22-04-11
22-04-11
22-04-11
22-04-11
22-04-11
23-03-06
23-03-06
23-03-06
23-03-06
23-03-06
23-03-06
23-03-06
23-03-06
23-03-06
23-03-06